Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Guney I et al. – Spironolactone reduced both proteinuria and urinary TGF–beta1 excretion in CKD patients. It is considered that spironolactone would be beneficial to prevent progression of renal fibrosis in CKD.


Related Articles

Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09    Relevance Score: 83%

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
Kidney International, 11/19/09    Relevance Score: 82%

Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial
Nephrology Dialysis Transplantation, 11/17/09    Relevance Score: 82%

Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09    Relevance Score: 82%

So Just What Can I Eat? Nutritional Care in Patients with Diabetes Mellitus and Chronic Kidney Disease
Nephrology Nursing Journal, 10/06/09    Relevance Score: 82%

Today in Chronic Dz/Renal Failure...keeping you current

Potential New Therapeutic Agents for Diabetic Kidney Disease
American Journal of Kidney Diseases, 02/09/10

Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy
Journal of Obstetrics and Gynaecology Research, 02/09/10

Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril
Pharmacoepidemiology and Drug Safety, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address